{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:26:16Z","timestamp":1790439976618,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"am","delay-in-days":296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["CB10246"],"award-info":[{"award-number":["CB10246"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.antiviral.2019.06.001","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T11:10:47Z","timestamp":1560165047000},"page":"104529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques"],"prefix":"10.1016","volume":"170","author":[{"given":"Nicole","family":"Espy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse","family":"Nagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Chitty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Sanchez-Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.06.001_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2015.03.022","article-title":"Viral quasispecies","volume":"479\u2013480","author":"Andino","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.06.001_bib2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03679","article-title":"Favipiravir elicits antiviral mutagenesis during virus replication in vivo","volume":"3","author":"Arias","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.antiviral.2019.06.001_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/AAC.38.5.1008","article-title":"Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription","volume":"38","author":"Arts","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.06.001_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/AAC.40.3.527","article-title":"Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription","volume":"40","author":"Arts","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.06.001_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jhep.2005.05.032","article-title":"Mutagenic effects of ribavirin and response to interferon\/ribavirin combination therapy in chronic hepatitis C","volume":"43","author":"Asahina","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.06.001_bib6","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.06.001_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2017.12.021","article-title":"Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus","volume":"151","author":"Bixler","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.06.001_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385118-5.00005-0","article-title":"A strand-specific library preparation protocol for RNA sequencing","volume":"500","author":"Borodina","year":"2011","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.antiviral.2019.06.001_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrd.2017.251","article-title":"Post-exposure treatments for Ebola and Marburg virus infections","volume":"17","author":"Cross","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.06.001_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S1286-4579(02)00008-4","article-title":"Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin","volume":"4","author":"Crotty","year":"2002","journal-title":"Microb. Infect."},{"key":"10.1016\/j.antiviral.2019.06.001_bib11","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.06.001_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164691","article-title":"Lethal mutagenesis of hepatitis C virus induced by favipiravir","volume":"11","author":"de Avila","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.06.001_bib13","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2019.06.001_bib14","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/JVI.02778-12","article-title":"Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients","volume":"87","author":"Dietz","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.06.001_bib15","doi-asserted-by":"crossref","first-page":"13910","DOI":"10.1073\/pnas.96.24.13910","article-title":"Mutation rates among RNA viruses","volume":"96","author":"Drake","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.06.001_bib16","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/infdis\/jiy163","article-title":"Ribavirin had demonstrable effects on the crimean-Congo hemorrhagic fever virus (CCHFV) population and load in a patient with CCHF infection","volume":"217","author":"Espy","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.06.001_bib17","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1128\/AAC.02666-14","article-title":"Efficiency of incorporation and chain termination determines the inhibition potency of 2'-modified nucleotide analogs against hepatitis C virus polymerase","volume":"58","author":"Fung","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.06.001_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002535","article-title":"Antiviral efficacy of favipiravir against Ebola virus: a translational study in cynomolgus macaques","volume":"15","author":"Guedj","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2019.06.001_bib19","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.antiviral.2019.06.001_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068347","article-title":"The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.06.001_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050316","article-title":"Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection","volume":"7","author":"Kugelman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.06.001_bib22","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.celrep.2015.08.038","article-title":"Emergence of ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail","volume":"12","author":"Kugelman","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2019.06.001_bib23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3201\/eid2107.150522","volume":"21","author":"Kugelman","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.06.001_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150919","article-title":"Informing the historical record of experimental nonhuman primate infections with ebola virus: genomic characterization of USAMRIID ebola virus\/H.sapiens-tc\/COD\/1995\/Kikwit-9510621 challenge stock \"R4368\" and its replacement \"R4415\"","volume":"11","author":"Kugelman","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.06.001_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171333","article-title":"Error baseline rates of five sample preparation methods used to characterize RNA virus populations","volume":"12","author":"Kugelman","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.06.001_bib26","article-title":"Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies. Archives of virology","volume":"20","author":"Kuhn","year":"2008","journal-title":"Supplement"},{"key":"10.1016\/j.antiviral.2019.06.001_bib27","article-title":"MOSAIK: a hash-based algorithm for accurate next-generation sequencing short-read mapping","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.06.001_bib28","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2019.06.001_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005389","article-title":"Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted","volume":"11","author":"Nguyen","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.06.001_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.06.001_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0168-1702(93)90063-S","article-title":"Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus","volume":"29","author":"Sanchez","year":"1993","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2019.06.001_bib32","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral mutation rates","volume":"84","author":"Sanjuan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.06.001_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02011-14","article-title":"Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells","volume":"5","author":"Shabman","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2019.06.001_bib34","article-title":"Correction: experimental treatment with favipiravir for ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2019.06.001_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2014.01.012","article-title":"Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model","volume":"104","author":"Smither","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.06.001_bib36","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1128\/AAC.01156-16","article-title":"Distinct effects of T-705 (favipiravir) and ribavirin on influenza virus replication and viral RNA synthesis","volume":"60","author":"Vanderlinden","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.06.001_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02344-14","article-title":"A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection","volume":"6","author":"Warren","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2019.06.001_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.06.001_bib39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.celrep.2018.01.008","article-title":"Active ebola virus replication and heterogeneous evolutionary rates in EVD survivors","volume":"22","author":"Whitmer","year":"2018","journal-title":"Cell Rep."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219303109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219303109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:29:40Z","timestamp":1759062580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219303109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":39,"alternative-id":["S0166354219303109"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.06.001","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104529"}}